Ipilimumab vs Lutetium Lu-177 Vipivotide Tetraxetan

## Ipilimumab vs Lutetium Lu-177 Vipivotide Tetraxetan: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Lutetium Lu-177 Vipivotide Tetraxetan**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Lutetium Lu-177 Vipivotide Tetraxetan — N/A.

## Chemical Properties

**Type**: Ipilimumab — Antibody; Lutetium Lu-177 Vipivotide Tetraxetan — Protein.